Furthermore, the p53 inhibition may limit the nuclear aggregation of DPP4 in CRC cells, while p53 overexpression results in DPP4 being concentrated in the nuclei and not binding to NOX1 [88]. Here, DPP4 is linked to colorectal carcinoma.